MBS608822
Epilepsy, Progressive Myoclonus Type 2A (Lafora Disease, EPM2A, Laforin, LD, LDE, EPM2, MELF, LAFPTPase, FLJ11207, KIAA0766)

Size
POA
- SKU:
- MBS608822
- Additional Names:
- [Epilepsy, progressive myoclonus type 2A, Lafora disease (laforin); Laforin; laforin; LAFPTPase; lafora PTPase; OTTHUMP00000017360; OTTHUMP00000017361; epilepsy, progressive myoclonus type 2, Lafora disease (laforin); epilepsy, progressive myoclonus type 2A, Lafora disease (laforin); Lafora PTPase]
- Application:
- WB
- Purity:
- Affinity Purified<br>Purified by Protein G immunoaffinity chromatography.
- Storage Conditions:
- Lyophilized powder may be stored at -20 degree C. Stable for 12 months at -20 degree C. Reconstitute by adding sterile 40-50% glycerol, aliquot and store at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
- Supplier:
- MyBiosource
- Host:
- Mouse
- Reactivities:
- Human
- Clone:
- [9H116]
- Uniprot:
- O95278
